TROW Stock Analysis: T. Rowe Price | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 23.584m USD | 12M Return: 12.3% | US74144T1088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 199M
EPS Trend: 96.2%
Qual. Beats: 0
Rev. Trend: 97.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
T. Rowe Price Group, Inc. (NASDAQ: TROW) is a publicly traded investment manager founded in 1937 and headquartered in Baltimore, Maryland. The firm offers investment management services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions, managing both equity and fixed income mutual funds across global public markets.
The firm employs fundamental and quantitative analysis using a bottom-up approach, combining in-house and external research. It integrates socially responsible investing principles, focusing on environmental, social, and governance (ESG) issues, and also participates in late-stage venture capital transactions, typically investing between $3 million and $5 million per deal.
As a large-cap company in the Financials sector, specifically the Asset Management & Custody Banks sub-industry, T. Rowe Price has operated since 1937 and went public in September 1989. The firm maintains offices across North America, Europe, Asia, and Australia, supporting its global investment operations. Previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc., the company has evolved into one of the established players in the asset management industry, generating revenue primarily through management fees on its mutual fund and advisory assets.
- S&P 500 strength lifts AUM and investment advisory fees
- Net outflows persist amid shift to low-cost passive ETFs
- Special dividends and buybacks fuel aggressive capital returns
| Net Income: 2.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 4.17 > 1.0 |
| NWC/Revenue: 29.77% < 20% (prev 50.20%; Δ -20.43% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.31b > Net Income 2.22b |
| Net Debt (-2.80b) to EBITDA (2.85b): -0.99 < 3 |
| Current Ratio: 2.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (214.2m) vs 12m ago -2.81% < -2% |
| Gross Margin: 70.75% > 18% (prev 51.27%; Δ 19.48% > 0.5%) |
| Asset Turnover: 51.13% > 50% (prev 49.49%; Δ 1.64% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.15 (Total Current Assets 4.18b - Total Current Liabilities 1.92b) / Total Assets 15.4b |
| B: 0.72 (Retained Earnings 11.0b / Total Assets 15.4b) |
| C: 0.17 (EBIT TTM 2.49b / Avg Total Assets 14.8b) |
| D: 3.46 (Book Value of Equity 11.0b / Total Liabilities 3.18b) |
| Altman-Z'' = 8.06 = AAA |
| DSRI: 1.02 (Receivables 941.6m/861.8m, Revenue 7.59b/7.10b) |
| GMI: 0.72 (GM 51.27% / 70.75%) |
| AQI: 1.04 (AQ_t 0.65 / AQ_t-1 0.63) |
| SGI: 1.07 (Revenue 7.59b / 7.10b) |
| TATA: -0.01 (NI 2.22b - CFO 2.31b) / TA 15.4b) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of August 23, 2026, the stock is trading at USD 111.51 with a total of 1,275,666 shares traded. Over the past week, the price has changed by +0.86%, over one month by -5.19%, over three months by +10.69% and over the past year by +12.26%.
Current recommended Stop Loss: 108.10 (which is 3.1% or 1.4 ATR below the current price).
T. Rowe Price has received a consensus analysts rating of 2.79. Therefore, it is recommended to hold TROW.
- StrongBuy: 0
- Buy: 1
- Hold: 9
- Sell: 4
- StrongSell: 0
| Analysts Target Price | 109.9 | -1.4% |
P/E Trailing = 11.1677
P/E Forward = 11.2486
P/S = 3.1065
P/B = 2.2058
P/EG = 3.0414
Revenue TTM = 7.59b USD
EBIT TTM = 2.49b USD
EBITDA TTM = 2.85b USD
Long Term Debt = unknown (0.0)
Short Term Debt = 429.4m USD (from shortTermDebt, last quarter)
Debt = 429.4m USD (from shortLongTermDebtTotal, last quarter) (leases 429.4m already included)
Net Debt = -2.80b USD (calculated: Debt 429.4m - CCE 3.23b)
Enterprise Value = 20.8b USD (23.6b + Debt 429.4m - CCE 3.23b)
Interest Coverage Ratio = unknown (Ebit TTM 2.49b / Interest Expense TTM 0.0)
EV/FCF = 9.55x (Enterprise Value 20.8b / FCF TTM 2.18b)
FCF Yield = 10.47% (FCF TTM 2.18b / Enterprise Value 20.8b)
FCF Margin = 28.65% (FCF TTM 2.18b / Revenue TTM 7.59b)
Net Margin = 29.26% (Net Income TTM 2.22b / Revenue TTM 7.59b)
Gross Margin = 70.75% ((Revenue TTM 7.59b - Cost of Revenue TTM 2.22b) / Revenue TTM)
Gross Margin QoQ = 56.83% (prev 78.27%)
Tobins Q-Ratio = 1.35 (Enterprise Value 20.8b / Total Assets 15.4b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 429.4m)
Taxrate = 23.38% (709.9m / 3.04b)
NOPAT = 1.91b (EBIT 2.49b * (1 - 23.38%))
Current Ratio = 2.18 (Total Current Assets 4.18b / Total Current Liabilities 1.92b)
Debt / Equity = 0.04 (Debt 429.4m / totalStockholderEquity, last quarter 11.0b)
Debt / EBITDA = -0.99 (Net Debt -2.80b / EBITDA 2.85b)
Debt / FCF = -1.29 (Net Debt -2.80b / FCF TTM 2.18b)
Total Stockholder Equity = 10.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.96% (Net Income 2.22b / Total Assets 15.4b)
RoE = 20.45% (Net Income TTM 2.22b / Total Stockholder Equity 10.9b)
RoCE = 22.93% (EBIT 2.49b / Capital Employed (Equity 10.9b + L.T.Debt 0.0))
RoIC = 14.15% (NOPAT 1.91b / Invested Capital 13.5b)
WACC = 9.50% (E(23.6b)/V(24.0b) * Re(9.67%) + D(429.4m)/V(24.0b) * Rd(0.0%) * (1-Tc(0.23)))
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -59.21 | Cagr: -2.01%
[DCF] Terminal Value 74.35% ; FCFF base≈1.88b ; Y1≈2.15b ; Y5≈3.17b
[DCF] Fair Price = 199.1 (EV 39.7b - Net Debt -2.80b = Equity 42.5b / Shares 213.3m; r=9.50% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.16 | EPS CAGR: 11.05% | SUE: 0.39 | # QB: 0
Revenue Correlation: 97.82 | Revenue CAGR: 6.09% | SUE: -0.32 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.67 | Chg30d=+1.22% | Revisions=+73% | Analysts=11
EPS current Year (2026-12-31): EPS=10.20 | Chg30d=+2.52% | Revisions=+80% | GrowthEPS=+5.0% | GrowthRev=+4.9%
EPS next Year (2027-12-31): EPS=10.28 | Chg30d=+1.36% | Revisions=+67% | GrowthEPS=+0.8% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: +86% (up=31, down=1)